Related Experiment Video
Updated: Jun 19, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Severe thrombocytopenia in a patient with metastatic renal cell carcinoma
Anne Florcken1, Andreas Loew, Martin Koch
1Department of Hematology and Oncology, Charité-Universitatsmedizin Berlin, Germany. anne.floercken@charite.de
Background And Methods:
A 63-year-old woman was transferred to our institution with suspected metastatic renal cell carcinoma (mRCC). Biopsies of the kidney and hepatic lesions proved partly sarcomatoid-differentiated clear cell carcinoma. Initially presenting with fever of unknown origin, the patient was empirically treated with antibiotics, but the patient's condition deteriorated and she developed progressive severe thrombocytopenia followed by mild anemia. Several blood tests were done to identify the cause of the thrombocytopenia.
Results:
Radiologic imaging and clinical presentation showed rapidly progressive mRCC. Clinical and laboratory features were incompatible with severe sepsis, thrombotic thrombocytopenic purpura (TTP) or idiopathic thrombocytopenic purpura (ITP) and laboratory tests were negative for heparin-induced thrombocytopenia (HIT). The patient's current medication was changed to exclude potential drug-induced thrombocytopenia and the bone marrow was biopsied. The results showed massive bone marrow infiltration of RCC.
Conclusions:
Although very rare, bone marrow carcinosis can occur in patients with mRCC and may present a diagnostic challenge. It is associated with a very poor prognosis.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chronic Kidney Disease II: Clinical Manifestations
